EUVIMEDEUVIMED entdecken
Open Access

The TNFSF12/TWEAK Modulates Colonic Inflammatory Fibroblast Differentiation and Promotes Fibroblast–Monocyte Interactions

Carlos Matellan, Ciarán Kennedy iD, Miren Itxaso Santiago-Vela iD, Johanna Hochegger, Méabh B Ní Chathail iD, Amanda Wu, Christopher Shannon iD, Helen M Roche, Seema S Aceves, Catherine Godson, Mario C Manresa

The Journal of Immunology · 2024

DOI: 10.4049/jimmunol.2300762 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, 2024. Verfasst von Carlos Matellan und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomolecular and Biomedical Sciences, University College Dublin, Belfield, Dublin, Ireland. Hauptthemen laut MEDLINE: Cytokine TWEAK, Monocytes, Fibroblasts, Colon. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Science Foundation Ireland (SFI), Irish Research Council (An Chomhairle um Thaighde in Éirinn).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibroblasts acquire a proinflammatory phenotype in inflammatory bowel disease, but the factors driving this process and how fibroblasts contribute to mucosal immune responses are incompletely understood. TNF superfamily member 12 (TNFSF12, or TNF-like weak inducer of apoptosis [TWEAK]) has gained interest as a mediator of chronic inflammation. In this study, we explore its role as a driver of inflammatory responses in fibroblasts and its contribution to fibroblast–monocyte interaction using human primary colonic fibroblasts, THP-1 and primary monocytes. Recombinant human TWEAK induced the expression of cytokines, chemokines, and immune receptors in primary colonic fibroblasts. The TWEAK upregulated transcriptome shared 29% homology with a previously published transcriptional profile of inflammatory fibroblasts from ulcerative colitis. TWEAK elevated surface expression of activated fibroblast markers and adhesion molecules (podoplanin [PDPN], ICAM-1, and VCAM-1) and secretion of IL-6, CCL2, and CXCL10. In coculture, fibroblasts induced monocyte adhesion and secretion of CXCL1 and IL-8, and they promoted a CD14high/ICAM-1high phenotype in THP-1 cells, which was enhanced when fibroblasts were prestimulated with TWEAK. Primary monocytes in coculture with TWEAK-treated fibroblasts had altered surface expression of CD16 and triggering receptor expressed on myeloid cells-1 (TREM-1) as well as increased CXCL1 and CXCL10 secretion. Conversely, inhibition of the noncanonical NF-κB pathway on colonic fibroblasts with a NF-κB–inducing kinase small molecule inhibitor impaired their ability to induce a CD14high phenotype on monocytes. Our results indicate that TWEAK promotes an inflammatory fibroblast–monocyte crosstalk that may be amenable for therapeutic intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytokine TWEAKMonocytesFibroblastsColonCell DifferentiationHumansCell CommunicationInflammationTHP-1 CellsCoculture TechniquesCytokinesCell Adhesion

Substanzen

Cytokine TWEAKTNFSF12 protein, humanCytokines

Autor:innen und Institutionen

  • School of Biomolecular and Biomedical Sciences, University College Dublin, Belfield, Dublin, Ireland.
  • Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin, Ireland.
  • School of Medicine, Conway Institute of Biomolecular and biomedical Research, University College Dublin, Belfield, Dublin, Ireland.
  • Diabetes Complications Research Centre, University College Dublin, Belfield, Dublin, Ireland.
  • School of Public Health, Physiotherapy, and Sports Science, University College Dublin, Belfield, Dublin, Ireland.
  • Department of Pediatrics, School of Medicine, University of California San Diego, La Jolla, CA.

ORCID-Profile: Ciarán Kennedy, Miren Itxaso Santiago-Vela, Méabh B Ní Chathail, Christopher Shannon

Förderung

  • Science Foundation Ireland (SFI)
  • Irish Research Council (An Chomhairle um Thaighde in Éirinn)

Zitieren

APA

Matellan, C., Kennedy, C., Santiago-Vela, M. I., Hochegger, J., Ní Chathail, M. B., Wu, A., Shannon, C., Roche, H. M., Aceves, S. S., Godson, C., & Manresa, M. C. (2024). The TNFSF12/TWEAK Modulates Colonic Inflammatory Fibroblast Differentiation and Promotes Fibroblast–Monocyte Interactions. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2300762

Vancouver

Matellan C, Kennedy C, Santiago-Vela MI, Hochegger J, Ní Chathail MB, Wu A, et al. The TNFSF12/TWEAK Modulates Colonic Inflammatory Fibroblast Differentiation and Promotes Fibroblast–Monocyte Interactions. The Journal of Immunology. 2024. doi:10.4049/jimmunol.2300762

BibTeX
@article{Matellan2024,
  author = {Matellan, Carlos and Kennedy, Ciarán and Santiago-Vela, Miren Itxaso and Hochegger, Johanna and Ní Chathail, Méabh B and Wu, Amanda and Shannon, Christopher and Roche, Helen M and Aceves, Seema S and Godson, Catherine and Manresa, Mario C},
  title = {The TNFSF12/TWEAK Modulates Colonic Inflammatory Fibroblast Differentiation and Promotes Fibroblast–Monocyte Interactions},
  journal = {The Journal of Immunology},
  year = {2024},
  doi = {10.4049/jimmunol.2300762}
}
Kostenlos starten →